PEP protocol

chemotherapy protocol consisting of cisplatin, etoposide and peplomycin; used in treatment of refractory rhabdomyosarcoma of the prostate and testicular teratoma

Also Known As:

EBCi regimen

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - PEP protocol: 9
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - PEP protocol: 9
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - PEP protocol: 9
Inorganic Chemicals: 9
- Platinum Compounds: 768
  - Cisplatin: 47326
    - PEP protocol: 9
- Nitrogen Compounds: 67
  - Cisplatin: 47326
    - PEP protocol: 9
- Chlorine Compounds: 8
  - Cisplatin: 47326
    - PEP protocol: 9
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 567
        Etoposide: 10835
        PEP protocol: 9
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 567
        Etoposide: 10835
        PEP protocol: 9
Carbohydrates: 22516
- Glycosides: 2186
  - Glucosides: 655
    - Etoposide: 10835
      - PEP protocol: 9
- Glycoconjugates: 1370
  - Glycopeptides: 1966
    - Bleomycin: 10030
      - Peplomycin: 342
        PEP protocol: 9
Amino Acids, Peptides, and Proteins: 1
- Peptides: 84029
  - Glycopeptides: 1966
    - Bleomycin: 10030
      - Peplomycin: 342
        PEP protocol: 9

Ernest H Oertli Selected Research

Ernest H Oertli Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure